Prevalence of serum CEA and CA 19-9 elevation in patients with colorectal cancers at The Nairobi Hospital, Kenya

被引：0
|
作者：
Gatihi, M. [2 ]
Amayo, A. [2 ]
Kisia, N. [1 ]
机构：
[1] Nairobi Hosp, Nairobi, Kenya
[2] Univ Nairobi, Nairobi, Kenya
来源：
CLINICA CHIMICA ACTA | 2024年 / 558卷
关键词：
D O I：
10.1016/j.cca.2024.118829
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
P0050
引用
收藏
页码：4 / 4
页数：1
相关论文
共 50 条
  • [21] The prognostic value of serum CA 19-9 in patients with metastatic colorectal cancer.
    Mosgaard, Camilla Stedstrup
    Gramkow, Mathias Holsey
    Dehlendorff, Christian
    Nielsen, Dorte
    Pfeiffer, Per
    Qvortrup, Camilla
    Yilmaz, Mette K. N.
    Larsen, Ole
    Bojesen, Stig Egil
    Schou, Jakob Vasehus
    Boisen, Mogens Karsboel
    Johansen, Julia S.
    Jensen, Benny Vittrup
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Estimation of metastatic site selectiveness of CEA and CA 19-9 in patients affected by metastasized colorectal carcinoma
    Francesco, Buda
    Stimolo, A.
    Bergamo, O.
    Svenda, G.
    D'Agnolo, E.
    Aragona, P.
    Buda, C.
    La Torre, F.
    TUMOR BIOLOGY, 2006, 27 : 73 - 73
  • [23] Differences in plasma gastrin, CEA, and CA 19-9 concentration in patients with proximal and distal colorectal cancer
    Grzegorz Bombski
    Anita Gasiorowska
    Daria Orszulak-Michalak
    Beata Neneman
    Justyna Kotynia
    Janusz Strzelczyk
    Adam Janiak
    Ewa Malecka-Panas
    International Journal of Gastrointestinal Cancer, 2002, 31 : 155 - 163
  • [24] CEA, CA 19-9 and CA 72-4 improve the diagnostic accurary in gastrointestinal cancers
    Carpelan-Holmström, M
    Louhimo, J
    Stenman, UH
    Alfthan, H
    Haglund, C
    ANTICANCER RESEARCH, 2002, 22 (04) : 2311 - 2316
  • [25] USEFULNESS OF THE TUMOR-MARKER CA 195 COMPARED TO CA 19-9 AND CEA IN COLORECTAL-CARCINOMA PATIENTS
    AMMON, A
    EIFFERT, H
    LOSER, C
    STUBER, M
    BEYER, HJ
    TUMORDIAGNOSTIK & THERAPIE, 1992, 13 (05) : 196 - 200
  • [26] PREDICTIVE VALUE OF TUMORAL MARKERS (CEA AND CA 19-9) IN COLORECTAL-CANCER
    DESAIVE, C
    SERVAIS, R
    COLLETTE, J
    DENIS, D
    REGINSTER, JY
    FRANCHIMONT, P
    ACTA GASTRO-ENTEROLOGICA BELGICA, 1987, 50 (01): : 65 - 78
  • [27] CEA, CA 19-9 AND CA 12-5 IN NORMAL AND CARCINOMATOUS HUMAN COLORECTAL TISSUES
    QUENTMEIER, A
    SCHLAG, P
    TUMOUR BIOLOGY, 1986, 7 (04): : 230 - 230
  • [28] CA242 and total antioxidant levels in comparison to CEA and CA 19-9 in colorectal cancer
    Yasasever, V
    Oral, EN
    Camlica, H
    Dalay, N
    JOURNAL OF TUMOR MARKER ONCOLOGY, 1999, 14 (01): : 27 - 32
  • [29] CA 72-4, CA 19-9 and CEA in monitoring adjuvant and metastatic colorectal cancer
    Bria, E
    Trasatti, L
    Gelibter, A
    Larosa, G
    Marchei, GG
    Lauro, S
    Reale, MG
    Vecchione, A
    Frati, L
    ANNALS OF ONCOLOGY, 2000, 11 : 64 - 64
  • [30] Plasma gastrin, CEA and CA 19-9 concentrations differ in patients with proximal and distal colorectal cancer (CRC)
    Gasiorowska, A
    Orszulak-Michalak, D
    Bombski, G
    Kotynia, J
    Strzelczyk, J
    Janiak, A
    Malecka-Panas, EI
    GASTROENTEROLOGY, 2002, 122 (04) : A592 - A592
12345